Researchtopractice public
[search 0]

Download the App!

show episodes
 
Loading …
show series
 
Proceedings from part 1 of a 4-part webinar series. Featuring perspectives from Drs Daniel A Pollyea, Eytan M Stein and Andrew H Wei on the following topics: Introduction (0:00) Venetoclax combinations (16:54) FLT3 inhibitors (34:31) IDH inhibitors (43:42) Oral azacitidine (CC-486) (50:45) Secondary AML (57:49) Novel agents and strategies (1:01:05)…
 
Featuring slide presentations and related discussion from Drs Harold J Burstein and Lisa Carey, including the following topics: ER-Positive Breast Cancer, PARP Inhibitors and Sacituzumab Govitecan — Harold J Burstein, MD, PhD (0:00) HER2-Positive and Triple-Negative Breast Cancer — Lisa A Carey, MD (43:52) CME information and select publications…
 
Featuring perspectives from Drs Harold J Burstein and Lisa Carey on the following topics: ER-Positive, HER2-Negative Breast Cancer Introduction (0:00) CDK4/6 inhibitors for ER-positive breast cancer (3:53) Role of PI3K inhibitors for ER-positive metastatic breast cancer (mBC) (13:31) Use of genomic assays for patients with ER-positive breast cancer…
 
Featuring an interview with Dr Roy S Herbst, including the following topics: Localized Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation (0:00) Phase III ADAURA Trial — Study Design and Characteristics of Enrolled Patients (3:32) Efficacy Data from the Phase III ADAURA Study Evaluating Adjuvant Osimertinib in Resected NSCLC with an EGFR Muta…
 
Featuring perspectives from Drs Michael J Birrer, Kathleen Moore and David M O'Malley on the following topics: Introduction 0:00) Symptoms of ovarian cancer — Courtney Arn, CNP (7:38) Implications of genetic testing — Jaclyn Shaver, MS, APRN, CNP, WHNP (15:51) Evaluation of an ovarian mass — Paula J Anastasia, MN, RN, AOCN) (27:58) Case: A woman in…
 
Featuring slide presentations and related discussion from Dr Kristen K Ciombor and Prof Eric Van Cutsem, including the following topics: New Developments in the Use of Biomarker-Based Treatment for Metastatic Colorectal Cancer (mCRC) — Kristen K Ciombor, MD, MSCI (0:00) Key Considerations in the Selection and Sequencing of Therapies for Patients wi…
 
Featuring perspectives from Dr Kristen K Ciombor and Prof Eric Van Cutsem, including the following topics: Introduction (0:00) Case: A woman in her mid-60s with microsatellite stable (MSS) right-sided metastatic colorectal cancer (mCRC) with a KRAS G13B mutation and a tumor mutation burden (TMB) of 11 mut/Mb — Warren S Brenner, MD (3:00) Case: A wo…
 
Featuring an interview with Dr Laurie H Sehn on the following topics: Updates in diffuse large B-cell lymphoma (0:00) New data with mantle cell lymphoma (14:27) Latest clinical findings in Hodkin lymphoma and peripheral T-cell lymphoma (22:43) CME information and select publicationsBy Dr. Neil Love
 
Featuring a roundtable discussion with Drs Virginia F Borges, Sara Hurvitz and Ian E Krop, including the following topics: Introduction Impact of COVID-19 vaccinations on screening for breast cancer (0:00) Management of HER2-positive early breast cancer Case: A woman in her early 40s with ER/PR-positive, HER2-positive breast cancer achieves a patho…
 
Featuring an interview with Dr Natalie S Callander, including the following topics: Treatment of high-risk smoldering multiple myeloma (MM) with carfilzomib, lenalidomide and dexamethasone followed by maintenance lenalidomide: A Phase II clinical and correlative study (0:00) Early versus late autologous stem cell transplant for newly diagnosed MM: …
 
Proceedings from the first of 2 sessions on HER2-positive breast cancer. Featuring perspectives from Dr Erika Hamilton, including the following topics: Introduction and review of SABCS 2020 Educational Session on HER2-targeted therapy (0:00) Case: A 42-year-old premenopausal woman with ER-positive, HER2-positive, node-negative breast cancer — Lauri…
 
Proceedings from the first of 2 sessions on triple-negative breast cancer. Featuring perspectives from Dr P Kelly Marcom, including the following topics: Introduction and Review of San Antonio Breast Cancer Symposium 2020 Educational Session on Triple-Negative Breast Cancer (TNBC) (0:00) Optimal Integration of Immune Checkpoint Inhibitors into the …
 
Featuring slide presentations and related discussion from Drs Sumanta K Pal and David I Quinn, including the following topics: Renal Cell Cancer — David I Quinn, MBBS, PhD (0:00) Urothelial Bladder Cancer — Sumanta K Pal, MD (41:35) CME information and select publicationsBy Dr. Neil Love
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login